Exosomes Detection for the Prediction of the Efficacy and Adverse Reactions of Anlotinib in Patients With Advanced NSCLC

Status:
Not yet recruiting

Trial end date:
2025-10-31

Target enrollment:

Participant gender:

Exosomes detection for the prediction of the efficacy and adverse reactions of Anlotinib in patients with advanced NSCLC

N/A

Shanghai Chest Hospital

3D Medicines